MedTrace Logo

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

NCT06895681 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2026-05-04

No results posted yet for this study

Summary

This is a non-therapeutic clinical research biorepository protocol designed to obtain, store, and clinically annotate biospecimens from participants with hereditary cancers. Those biospecimens will be used to generate participant-derived tumor models that will serve as a resource to better understand hereditary cancers and develop new efficient therapies.

Conditions

  • Solid Tumor
  • Solid Tumor, Adult
  • Somatic Mutation
  • Solid Tumor, Unspecified, Adult
  • Hereditary Cancer

Interventions

PROCEDURE

Blood Sample

Obtained at the time of non-study related routine blood draw.

PROCEDURE

Tissue Sample

Obtained at the time of non-study related routine biopsy or surgical procedure.

PROCEDURE

Excess fluid Sample

Obtained at the time of non-study related routine biopsy, surgical procedure, paracentesis, or thoracentesis procedure.

OTHER

Medical Chart Review

Demographic, clinical, and pathologic information will be extracted from the medical record

Sponsors & Collaborators

Principal Investigators

  • Varun Monga, MBBS · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2035-12-31
Completion
2035-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06895681 on ClinicalTrials.gov